The lixisenatide trial
Another trial in the promising diabetes drug cohort for repurposing in Parkinson’s is evaluating the effect of lixisenatide on the progression of Parkinson’s. This trial is co-funded by Cure Parkinson’s and Van Andel Institute through the International Linked Clinical Trials programme. This study is being conducted in France…